oasis semaglutide 4 trial In the OASIS 4 phase 3 trial, once-daily oral semaglutide at ECO 2026 - OASIS 4:

Postural instability, which is more common in the advanced stages of PD, is one of the most challenging symptoms as it greatly increases fall risk

#GLP1 #PeptideTherapy #CravingControl #InsulinSupport #PrivatePractice To view or add a comment, sign in Common Side Effects of GLP1 Therapies GLP1 receptor agonists (like Ozempic, Wegovy, etc.) can offer significant benefits in weight and metabolic controlbut they come with possible side effects, including nausea, diarrhea, vomiting, constipation, and mild abdominal discomfort

Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes. New England Journal of Medicine , 389, 2221-2232

Each of these has to be in a good range preoperatively

Blood donation is one of the most meaningful ways to save lives

However, this hypothesis requires confirmation in a dedicated kidney outcome trial